Archon Biosciences, a biotech startup with $20 million in seed funding, is utilizing AI to design innovative biomolecules to enhance antibody treatments.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
Archon emerges from stealth with $20M and 'antibody cages' to power up drug development
